| A Lilly Drug Logs Success and Risks in Heart Trial http://www.nytimes.com/2007... Diabetes Articles New York Times - With or without prasugrel, Lilly’s near-term drug pipeline is relatively weak, although the company recently reported positive trial results from a long-acting version of Byetta, its injectable diabetes treatment. Lilly and Daiichi Sankyo also said ... |
| Takeda 1st-Half Net Surges 37% on Actos Diabetes Pill (Update1) http://www.bloomberg.com/ap... Diabetes Articles Bloomberg - Nov. 5 (Bloomberg) -- Takeda Pharmaceutical Co., Japan's largest drugmaker, said first-half profit rose 37 percent on higher sales of its Actos diabetes pill. Net income was 218 billion yen ($1.9 billion), or 256 yen a share, in the six months ended ... |
| McCain, Huckabee court seniors http://www.cnbc.com/id/2148... Diabetes Articles CNBC - Huckabee, the former Arkansas governor who has made his personal bout with diabetes and obesity a centerpiece of his campaign, said lowering medical costs would solve the nation's health care problems, not universal health care. "I don't trust the ... |
| Blue Cross Blue Shield of Michigan and Schools Partner to Get Kids ... http://www.forbes.com/prnew... Diabetes Articles Forbes - It is absolutely essential that young people receive encouragement to follow healthy lifestyles so we can reverse the trend we are seeing in childhood obesity and the early development of diseases such as diabetes," Rossi said. "We want to lower ... |
| Pharmacy Benefit Management Institute Research Confirms Employers ... http://www.forbes.com/busin... Diabetes Articles Forbes - In the United States, Takeda currently markets oral diabetes, insomnia, and gastroenterology treatments, and through Takeda Global Research & Development Center, Inc., the company has a robust pipeline with compounds in development for diabetes ... |
| Generex Biotechnology Makes Presentations At Annual Diabetes ... http://news.moneycentral.ms... Diabetes Articles MSN MoneyCentral - WORCESTER, Mass., Oct. 26, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has made five poster presentations ... |
| Abortion foes say court clears stem cell vote http://www.philly.com/phill... Diabetes Articles Philadelphia Inquirer - Corzine, legislators and others contend the borrowing could help produce cures for spinal cord injuries, diabetes, Parkinson's disease and other ailments, while attracting and retaining top scientists and research companies to the Garden State. New ... |
| Artificial Life, Inc. Hires and Appoints Global Controller http://news.moneycentral.ms... Diabetes Articles MSN MoneyCentral - In addition, after the acquisition of SMS Galaxy and the recent mobile diabetes system we are actively pursuing and evaluating further IP and corporate acquisitions and hence need to have more senior finance personal on board to handle the due ... |
| Micros Systems profit rises 41% http://www.baltimoresun.com... Diabetes Articles Baltimore Sun - This time Prochymal, made from the bone marrow of adult volunteers, will be used in mid-stage clinical trials as a treatment for type 1 diabetes. The Juvenile Diabetes Research Foundation has provided $4 million in funding for the project. The drug ... |
| ConnectiCare Ranked #5 Best Health Plan in America http://www.forbes.com/prnew... Diabetes Articles Forbes - Includes HEDIS measures of how well health plans take care of people who have health problems, such as asthma, diabetes, heart disease, hypertension, osteoporosis, alcohol and drug dependence, mental illness and whether physicians advised smokers to ... |